Rama Yarasani

Rama joined Alvogen in September 2018 and is responsible for all aspects of Generics and Brand R&D, including Biopharmaceutics, Clinical Pharmacology, Project Management,product transfers and commercial validation at all internal and external sites.

Rama is a seasoned executive with over twenty years in the pharmaceutical industry, with significant development experience in complex generics and 505(b)2 products. Most recently he was the Vice President and Generic R&D Site Head for the Teva Pharmaceuticals Elizabeth, New Jersey site. There he managed a R&D team involved in the development of complex generic products including first to file and first to market as well as some brand products for US market. Rama also oversaw the development of generic products for European, Mexican and Canadian markets. 

Rama holds a BS in Pharmaceutical Sciences, and a MS in Pharmaceutics and Ph.D. in Pharmaceutics all from Andhra University in India. He also has post-doctoral research experience at Kyoto Pharmaceutical University in Kyoto, Japan. In addition, he is the recipient of numerous awards for his work, as well as a published author for scientific research articles.